Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide Synthase Type I | 14 | 2022 | 51 | 4.530 |
Why?
|
| Gastroparesis | 9 | 2022 | 9 | 4.440 |
Why?
|
| NF-E2-Related Factor 2 | 12 | 2022 | 73 | 4.120 |
Why?
|
| Nitric Oxide | 12 | 2021 | 287 | 2.900 |
Why?
|
| Gastric Emptying | 9 | 2021 | 14 | 2.900 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2022 | 87 | 2.820 |
Why?
|
| Saliva | 3 | 2023 | 97 | 1.580 |
Why?
|
| Periodontal Diseases | 4 | 2017 | 49 | 1.350 |
Why?
|
| Diabetes Complications | 3 | 2019 | 91 | 1.290 |
Why?
|
| Pylorus | 3 | 2018 | 4 | 1.220 |
Why?
|
| Pterins | 3 | 2018 | 4 | 1.170 |
Why?
|
| Antioxidants | 6 | 2021 | 386 | 1.090 |
Why?
|
| Stomach | 4 | 2019 | 43 | 1.050 |
Why?
|
| Porphyromonas gingivalis | 3 | 2020 | 23 | 1.040 |
Why?
|
| Mesenteric Arteries | 3 | 2015 | 18 | 0.950 |
Why?
|
| Gastrointestinal Motility | 3 | 2018 | 18 | 0.930 |
Why?
|
| Estradiol | 6 | 2013 | 244 | 0.900 |
Why?
|
| Acrolein | 2 | 2021 | 15 | 0.890 |
Why?
|
| Animals | 32 | 2024 | 14307 | 0.880 |
Why?
|
| Mice, Knockout | 9 | 2022 | 897 | 0.830 |
Why?
|
| Obesity | 2 | 2020 | 965 | 0.830 |
Why?
|
| Maleimides | 1 | 2020 | 12 | 0.780 |
Why?
|
| Mice | 14 | 2022 | 5668 | 0.770 |
Why?
|
| Apolipoproteins E | 4 | 2015 | 129 | 0.770 |
Why?
|
| Mouth | 3 | 2017 | 44 | 0.750 |
Why?
|
| Hyperglycemia | 1 | 2020 | 53 | 0.730 |
Why?
|
| Pyloric Antrum | 3 | 2022 | 5 | 0.720 |
Why?
|
| Calcitonin Gene-Related Peptide | 6 | 2013 | 11 | 0.690 |
Why?
|
| Indoles | 1 | 2020 | 154 | 0.690 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 628 | 0.680 |
Why?
|
| Female | 27 | 2024 | 19873 | 0.680 |
Why?
|
| Bacteroidaceae Infections | 2 | 2015 | 6 | 0.670 |
Why?
|
| Diabetes Mellitus | 3 | 2018 | 465 | 0.630 |
Why?
|
| Muscle Relaxation | 5 | 2019 | 17 | 0.620 |
Why?
|
| Xerostomia | 1 | 2016 | 2 | 0.570 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2016 | 5 | 0.570 |
Why?
|
| Nitrergic Neurons | 2 | 2012 | 5 | 0.520 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 59 | 0.510 |
Why?
|
| Rats | 15 | 2018 | 3261 | 0.510 |
Why?
|
| Gastric Mucosa | 2 | 2012 | 50 | 0.510 |
Why?
|
| Oxidative Stress | 4 | 2021 | 874 | 0.510 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2016 | 1534 | 0.500 |
Why?
|
| Progesterone | 4 | 2013 | 117 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 1530 | 0.420 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 94 | 0.410 |
Why?
|
| Estrogens | 2 | 2013 | 190 | 0.410 |
Why?
|
| Receptors, LDL | 1 | 2011 | 30 | 0.390 |
Why?
|
| Kidney Diseases | 1 | 2013 | 159 | 0.390 |
Why?
|
| Vitamin D | 1 | 2013 | 176 | 0.390 |
Why?
|
| Diabetic Neuropathies | 1 | 2010 | 11 | 0.380 |
Why?
|
| Gonadal Steroid Hormones | 4 | 2020 | 50 | 0.380 |
Why?
|
| Sex Characteristics | 2 | 2011 | 213 | 0.370 |
Why?
|
| Hormones | 1 | 2009 | 51 | 0.340 |
Why?
|
| Atherosclerosis | 3 | 2015 | 131 | 0.340 |
Why?
|
| Endothelium, Vascular | 4 | 2020 | 229 | 0.330 |
Why?
|
| Humans | 15 | 2024 | 34853 | 0.300 |
Why?
|
| Risk Factors | 6 | 2023 | 3414 | 0.290 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 9 | 0.280 |
Why?
|
| Blotting, Western | 4 | 2014 | 834 | 0.280 |
Why?
|
| Flutamide | 1 | 2005 | 7 | 0.270 |
Why?
|
| Diet, Protein-Restricted | 1 | 2005 | 5 | 0.270 |
Why?
|
| Aorta | 3 | 2015 | 161 | 0.260 |
Why?
|
| Treponema denticola | 2 | 2015 | 5 | 0.260 |
Why?
|
| Sex Factors | 4 | 2013 | 859 | 0.260 |
Why?
|
| Aging | 2 | 2009 | 639 | 0.250 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2015 | 21 | 0.250 |
Why?
|
| Blood Glucose | 3 | 2011 | 333 | 0.250 |
Why?
|
| RNA, Messenger | 4 | 2018 | 1152 | 0.240 |
Why?
|
| Gene Expression | 3 | 2021 | 639 | 0.240 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2016 | 63 | 0.230 |
Why?
|
| Male | 17 | 2015 | 18870 | 0.230 |
Why?
|
| Dental Caries | 1 | 2024 | 54 | 0.230 |
Why?
|
| Pain | 1 | 2006 | 249 | 0.230 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2561 | 0.220 |
Why?
|
| Periodontitis | 2 | 2014 | 52 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 592 | 0.220 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2022 | 27 | 0.210 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 284 | 0.210 |
Why?
|
| Signal Transduction | 3 | 2021 | 1802 | 0.210 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 149 | 0.200 |
Why?
|
| Curcumin | 1 | 2021 | 66 | 0.190 |
Why?
|
| Cytokines | 2 | 2022 | 569 | 0.190 |
Why?
|
| Down-Regulation | 2 | 2013 | 420 | 0.190 |
Why?
|
| Weight Gain | 1 | 2021 | 128 | 0.180 |
Why?
|
| Vasodilation | 3 | 2010 | 65 | 0.170 |
Why?
|
| Glucose | 1 | 2020 | 217 | 0.170 |
Why?
|
| Dimerization | 2 | 2010 | 102 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 93 | 0.170 |
Why?
|
| Body Weight | 2 | 2011 | 404 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2020 | 177 | 0.170 |
Why?
|
| Vasomotor System | 2 | 2011 | 3 | 0.160 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2018 | 47 | 0.160 |
Why?
|
| Prevalence | 1 | 2023 | 1425 | 0.160 |
Why?
|
| Brain | 1 | 2006 | 1268 | 0.160 |
Why?
|
| Rats, Wistar | 1 | 2018 | 202 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 1300 | 0.160 |
Why?
|
| Hypertension | 1 | 2005 | 770 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2020 | 296 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 162 | 0.150 |
Why?
|
| NG-Nitroarginine Methyl Ester | 4 | 2007 | 34 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 41 | 0.150 |
Why?
|
| Myositis | 2 | 2006 | 7 | 0.140 |
Why?
|
| Hyperalgesia | 2 | 2006 | 15 | 0.140 |
Why?
|
| Chronic Disease | 3 | 2015 | 469 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 445 | 0.140 |
Why?
|
| Fusobacterium nucleatum | 1 | 2015 | 8 | 0.130 |
Why?
|
| Biofilms | 1 | 2017 | 166 | 0.130 |
Why?
|
| Bacteroidetes | 1 | 2015 | 9 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2017 | 628 | 0.130 |
Why?
|
| alpha-Globins | 1 | 2014 | 3 | 0.130 |
Why?
|
| Adrenomedullin | 3 | 2010 | 4 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2015 | 156 | 0.130 |
Why?
|
| Logistic Models | 1 | 2017 | 894 | 0.130 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 49 | 0.120 |
Why?
|
| Crohn Disease | 1 | 2014 | 55 | 0.120 |
Why?
|
| Colon | 1 | 2014 | 98 | 0.120 |
Why?
|
| Ovariectomy | 3 | 2010 | 104 | 0.120 |
Why?
|
| Inflammation | 2 | 2015 | 577 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2018 | 386 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 184 | 0.120 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 47 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 35 | 0.110 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 9 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 32 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 181 | 0.110 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 35 | 0.110 |
Why?
|
| Random Allocation | 1 | 2012 | 139 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2012 | 528 | 0.100 |
Why?
|
| Peptide Fragments | 3 | 2013 | 298 | 0.100 |
Why?
|
| Receptors, Calcitonin | 2 | 2009 | 3 | 0.100 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2011 | 22 | 0.100 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2011 | 17 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2017 | 583 | 0.100 |
Why?
|
| Peptides | 2 | 2005 | 308 | 0.100 |
Why?
|
| Heart | 1 | 2013 | 178 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2012 | 113 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 406 | 0.100 |
Why?
|
| Uterine Artery | 1 | 2010 | 2 | 0.100 |
Why?
|
| Methotrexate | 1 | 2010 | 20 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 61 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 555 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2010 | 486 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 147 | 0.090 |
Why?
|
| Hypoxanthines | 1 | 2010 | 3 | 0.090 |
Why?
|
| GTP Cyclohydrolase | 1 | 2010 | 4 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 72 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2005 | 613 | 0.090 |
Why?
|
| Pregnancy | 5 | 2010 | 1503 | 0.090 |
Why?
|
| Trigeminal Ganglion | 2 | 2006 | 13 | 0.090 |
Why?
|
| Ganglia, Spinal | 1 | 2009 | 36 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2010 | 196 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 84 | 0.080 |
Why?
|
| Middle Aged | 3 | 2017 | 9642 | 0.080 |
Why?
|
| Vasodilator Agents | 2 | 2010 | 54 | 0.080 |
Why?
|
| Tetrodotoxin | 1 | 2007 | 20 | 0.080 |
Why?
|
| Pressure | 1 | 2007 | 36 | 0.080 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 51 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2007 | 63 | 0.070 |
Why?
|
| Electric Stimulation | 1 | 2007 | 177 | 0.070 |
Why?
|
| Placenta | 2 | 2004 | 91 | 0.070 |
Why?
|
| Adult | 3 | 2017 | 11034 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2005 | 57 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2003 | 396 | 0.070 |
Why?
|
| Gestational Age | 1 | 2005 | 190 | 0.060 |
Why?
|
| Antibodies, Bacterial | 2 | 2015 | 107 | 0.060 |
Why?
|
| Oral Hygiene | 1 | 2024 | 15 | 0.060 |
Why?
|
| Fetus | 1 | 2004 | 103 | 0.060 |
Why?
|
| Beverages | 1 | 2024 | 64 | 0.060 |
Why?
|
| Oral Health | 1 | 2024 | 61 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2003 | 51 | 0.050 |
Why?
|
| Cattle | 1 | 2024 | 472 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2003 | 57 | 0.050 |
Why?
|
| Fertility | 1 | 2002 | 59 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 968 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2002 | 323 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 155 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 605 | 0.040 |
Why?
|
| Nitroglycerin | 1 | 1996 | 7 | 0.040 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1996 | 21 | 0.040 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1996 | 44 | 0.040 |
Why?
|
| Child | 1 | 2024 | 2875 | 0.030 |
Why?
|
| Gingival Diseases | 1 | 2015 | 3 | 0.030 |
Why?
|
| Bone Density | 1 | 1996 | 76 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 23 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 2015 | 18 | 0.030 |
Why?
|
| Serum Amyloid A Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| Bacteremia | 1 | 2015 | 31 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 81 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2015 | 61 | 0.030 |
Why?
|
| Comet Assay | 1 | 2014 | 72 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2014 | 7 | 0.030 |
Why?
|
| Gingivitis | 1 | 2014 | 7 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 49 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 100 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 984 | 0.030 |
Why?
|
| Behavior, Animal | 2 | 2006 | 304 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 232 | 0.030 |
Why?
|
| Sarcomeres | 1 | 2013 | 8 | 0.030 |
Why?
|
| Cell Separation | 1 | 2013 | 91 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 580 | 0.030 |
Why?
|
| Litter Size | 2 | 2003 | 12 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2013 | 97 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 104 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2013 | 95 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 416 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 707 | 0.030 |
Why?
|
| DNA Damage | 1 | 2014 | 341 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 964 | 0.030 |
Why?
|
| Aged | 2 | 2014 | 6448 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 818 | 0.030 |
Why?
|
| Risk | 1 | 2012 | 256 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 165 | 0.020 |
Why?
|
| Glyburide | 1 | 2010 | 8 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2010 | 30 | 0.020 |
Why?
|
| Calcium | 1 | 2013 | 445 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2333 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 14 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2006 | 66 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2006 | 75 | 0.020 |
Why?
|
| Masseter Muscle | 1 | 2005 | 4 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2005 | 33 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 2005 | 41 | 0.020 |
Why?
|
| Substance P | 1 | 2005 | 25 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 4012 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 859 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 5035 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 197 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 490 | 0.010 |
Why?
|
| Fetal Weight | 1 | 2003 | 9 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 48 | 0.010 |
Why?
|
| Systole | 1 | 2003 | 65 | 0.010 |
Why?
|
| Growth | 1 | 2002 | 12 | 0.010 |
Why?
|
| United States | 1 | 2012 | 3894 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 1681 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 204 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 1349 | 0.010 |
Why?
|
| Birth Weight | 1 | 2002 | 93 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 1996 | 73 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 62 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1996 | 171 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 103 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1996 | 217 | 0.010 |
Why?
|